Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

4.41
Delayed Data
As of May 05
 -0.30 / -6.37%
Today’s Change
1.46
Today|||52-Week Range
6.37
+179.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization89.0K90.0K98.0K67.0K
 
 
 
 
 
 
Operating ExpensesGross Income-89.0K-90.0K-98.0K-67.0K
 
 
 
 
 
General Expenses7.5M6.8M6.6M7.2M
 
 
 
 
 
Research And Development5.8M5.3M5.3M5.5M
 
 
 
 
 
Total Operating Expenses7.6M6.9M6.7M7.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-6.9M-6.7M-7.3M
 
 
 
 
 
Interest Expense On Debt259.0K360.0K286.0K144.0K
 
 
 
 
 
Other Expenses-48.0K-31.0K-14.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.9M-7.3M-7.0M-7.4M
 
 
 
 
 
Net Income-7.9M-7.3M-7.0M-7.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.1M21.5M22.7M22.9M
 
 
 
 
 
Shares To Calculate EPS Diluted20.1M21.5M22.7M22.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.39-$0.34-$0.31-$0.32
 
 
 
 
 
EPS Diluted-$0.39-$0.34-$0.31-$0.32
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account